Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/05/1998US5747511 Treatment of herpes infections
05/05/1998US5747510 Pharmaceutical unit dosage formulations
05/05/1998US5747509 Prevention of occlusion in arteries
05/05/1998US5747508 Amidinohydrazones of ketones derived from benzo B!furan, methods for their production, and pharmaceuticals containing these compounds
05/05/1998US5747507 Myocardial disease
05/05/1998US5747506 Antihistamines, bronchodilator agents; asthma
05/05/1998US5747505 Heterocyclic aryl-, alkyl- and cycloalkylacetamides
05/05/1998US5747503 Indeno(1,2b)pyroles
05/05/1998US5747502 Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents
05/05/1998US5747501 Indole derivatives
05/05/1998US5747500 Antiviral 2, 4-pyrimidinedione derivatives
05/05/1998US5747499 Cyclopentaquinazoline compounds cyclopentaquinazoline compounds
05/05/1998US5747496 Inhibitors of platelet aggregation
05/05/1998US5747495 Method for treating hypertension using pyrazolopyrimidine derivatives
05/05/1998US5747494 Pharmaceutical compositions for the treatment of depressive disorders
05/05/1998US5747493 Dopamine re-uptake inhibitor
05/05/1998US5747492 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by ampa receptors
05/05/1998US5747491 Morpholine derivatives and their use as antagonists of tachikinins
05/05/1998US5747489 Arylalkyl-thiadiazinones
05/05/1998US5747488 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
05/05/1998US5747485 Respiratory system disorders
05/05/1998US5747484 Bactericides
05/05/1998US5747483 Antibiotics and bactericides
05/05/1998US5747482 Methods and compositions to inhibit keratinocyte proliferation
05/05/1998US5747481 Analgesics and antiinflammaory agents
05/05/1998US5747480 Oral contraceptive
05/05/1998US5747478 Vitamin D3 analogs for the treatment of psoriasis and sebaceous gland diseases
05/05/1998US5747477 Azo derivatives of 5-aminosalicylic acid
05/05/1998US5747476 Mixture of pyrimethamine and a sulfonamide compound
05/05/1998US5747475 Chitosan-derived biomaterials
05/05/1998US5747473 L-nucleoside analogues and pharmaceutical compositions
05/05/1998US5747472 Anticarcinogenic agents and antitumor agents
05/05/1998US5747469 Methods and compositions comprising DNA damaging agents and p53
05/05/1998US5747468 Polydiallyldimethylammonium chloride with saccharides and ethers
05/05/1998US5747467 Erythromycins
05/05/1998US5747465 Sugar derivatives of macrolides
05/05/1998US5747464 Prevent absorption of fat and cholesterol
05/05/1998US5747462 Pharmaceutically active compounds and their use
05/05/1998US5747319 Human mRNA editing enzyme
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747314 Nucleotides and genetic vectors
05/05/1998US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747300 Culture of nutrients of maltose micrcoorganism with enzymes
05/05/1998US5747295 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
05/05/1998US5747288 Protein kinase required for Ras signal transduction
05/05/1998US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
05/05/1998US5747275 Protein kinase required for RAS signal transduction
05/05/1998US5747250 Probe for tumour diagnostics or tumour therapy
05/05/1998US5747071 Blood replacements
05/05/1998US5747070 Methods for the treatment of herpes virus infections
05/05/1998US5747068 Flouxetine pharmaceutical formulations
05/05/1998US5747066 Mixed micelles
05/05/1998US5747065 Monoglyceride/lactate ester permeation enhancer for oxybutynin
05/05/1998US5747061 Suspension of loteprednol etabonate for ear, eye, or nose treatment
05/05/1998US5747060 Prolonged local anesthesia with colchicine
05/05/1998US5747059 Diphenylchromans
05/05/1998US5747049 Aminoethylsulfinic acid or aminoethylthiosulfonic acid, sunscreen
05/05/1998US5747037 Monoclonal antibodies bound to epitopes secreted by hybridomas
05/05/1998US5747034 Methods and materials for the induction of T cell anergy
05/05/1998US5747026 Antioxidants
05/05/1998US5747023 Cancer therapy using lymphotoxin
05/05/1998US5747005 Oil-based, anti-plaque dentifrice composition
05/05/1998US5747001 Aerosols containing beclomethazone nanoparticle dispersions
05/05/1998US5746995 Diethylenetriaminepentaacetic acid
05/05/1998CA2152588C Anti-androgenic cyclo and bicyclo alkenes
05/05/1998CA2152350C Reduction of hair growth employing sulfhydryl reactive compounds
05/05/1998CA2109956C Nitroglycerine plaster and process for making it
05/05/1998CA2100126C 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
05/05/1998CA2088588C Treatment of hair loss and dermatological problems
05/05/1998CA2084730C Skin antiseptic and hand disinfectant
05/05/1998CA2073567C Spicamycin derivatives and the use thereof
05/05/1998CA1339854C Viral treatment system
04/1998
04/30/1998WO1998017815A1 Retroviral vectors
04/30/1998WO1998017806A1 Mini-e1a genes and gene products
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017797A1 ANTI-ErbB2 ANTIBODIES
04/30/1998WO1998017796A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
04/30/1998WO1998017779A1 NOVEL FabH
04/30/1998WO1998017707A1 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
04/30/1998WO1998017689A2 Il-12 gene expression and delivery systems and uses
04/30/1998WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998WO1998017676A1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof
04/30/1998WO1998017673A1 Isosorbide aspirinate esters
04/30/1998WO1998017672A1 Substituted aminoalkane phosphonic acids
04/30/1998WO1998017671A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same
04/30/1998WO1998017668A1 Thienopyrimidine with phosphodiesterase v inhibiting effect
04/30/1998WO1998017667A1 6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice
04/30/1998WO1998017663A1 Novel genipin derivative having anti hepatitis b virus activity
04/30/1998WO1998017662A1 Phenyl-substituted bicyclic heterocyclyl derivatives and their use
04/30/1998WO1998017659A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
04/30/1998WO1998017655A1 Metalloproteinase inhibitors
04/30/1998WO1998017652A1 Oxadiazoles, processes for their preparation and their use as medicaments
04/30/1998WO1998017651A1 1-phenyl-benzimidazole compounds and their use as baga-a receptor modulators
04/30/1998WO1998017650A1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
04/30/1998WO1998017649A1 Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide
04/30/1998WO1998017648A1 Anthranilic acid derivatives as multi drug resistance modulators
04/30/1998WO1998017647A1 Piperidine compounds
04/30/1998WO1998017645A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
04/30/1998WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors
1 ... 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 6675 6676 6677 6678 6679 6680 ... 7860